SCHEMBL5748124

SCHEMBL5748124

CC(=O)Nc1nc(-c2ccc(F)c3ccccc23)cc(C(C)C)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 1/20 0.62
HTR2B P41595 1/20 0.62
GPR65 Q8IYL9 1/20 0.62
ADORA3 P0DMS8 6/20 0.47
ADORA1 P30542 5/20 0.47
ADORA2A P29274 3/20 0.44
ADORA2B P29275 1/20 0.43
NUDT1 P36639 1/20 0.40
KDM4E B2RXH2 3/20 0.37
NPSR1 Q6W5P4 2/20 0.37
RECQL P46063 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
ACHE P22303 2/20 0.37
APP P05067 1/20 0.37
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7076008 0.88 HTR1B (0.56) HTR1BHTR2BGPR65ADORA3ADORA1
SCHEMBL7079645 0.85 HTR1B (0.58) HTR1BHTR2BGPR65ADORA3ADORA1
SCHEMBL5745878 0.85 HTR1B (0.67) HTR1BHTR2BGPR65ADORA3ADORA1
SCHEMBL7074778 0.83 HTR1B (0.56) HTR1BHTR2BGPR65ADORA3ADORA1
Hydrochloric Acid SCHEMBL5750394 0.82 HTR1B (0.68) HTR1BHTR2BGPR65ADORA3ADORA1
SCHEMBL5746388 0.82 HTR1B (0.64) HTR1BHTR2BGPR65ADORA1ADORA2A
SCHEMBL5750023 0.81 HTR1B (0.63) HTR1BHTR2BGPR65SMN1; SMN2ALOX15
SCHEMBL5750582 0.81 HTR1B (0.63) HTR1BHTR2BGPR65ADORA3ADORA1
SCHEMBL8387117 0.80 HTR1B (0.53) HTR1BHTR2BGPR65ADORA3ADORA1
SCHEMBL8387114 0.80 HTR1B (0.53) HTR1BHTR2BGPR65ADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0901474-B1 ARYL PYRIMIDINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2006-04-19 EP disclosed
EP-1321169-A1 Combination of a serotonin receptor antagonist with a histidine decarboxylase inhibitor as a medicament Biofrontera Pharmaceuticals AG (DE) 2003-06-25 EP disclosed
CN-1109675-C Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 2003-05-28 CN disclosed
US-5958934-A 5-HT 2B ANTAGONIST SYNTEX (U.S.A.) INC. (US) 1999-09-28 US disclosed
US-5952331-A SELECTIVE 5HT2B ANTAGONISTS; SEROTONIN RECEPTOR ANTAGONIST; TREATING DISORDERS OF THE GASTROINTESTINAL TRACK, RESTENOSIS, ASTHMA AND OBSTRUCTIVE AIRWAY DISEASE, PROSTATIC HYPERPLASIA, GENERALIZED ANXIETY, PANIC DISORDER SYNTEX (USA) INC. (US) 1999-09-14 US disclosed
CN-1223641-A Aryl pyrimidine derivatives HOFFMANN LA ROCHE (CH) 1999-07-21 CN disclosed
EP-0901474-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-03-17 EP disclosed
US-5863924-A Aryl pyrimidine derivatives SYNTEX (U.S.A.) INC. (US) 1999-01-26 US disclosed
WO-1997044326-A1 ARYL PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1997-11-27 WO disclosed